Botanical drugs for treating erectile dysfunction: clinical evidence

Botanical drugs for treating erectile dysfunction: clinical evidence

Phosphodiesterase-5 inhibitors (PDE5-i) have been widely used in clinical practice for the treatment of erectile dysfunction (ED). However, due to its suboptimal therapeutic effects and side effects, it is necessary to develop new medicines for ED treatment. Botanical drugs have been widely investig...

Full description

Bibliographic Details
Main Authors:	Dengjianyi Xu, Yucong Zhang, Jian Bai, Huixing Yuan, Tao Wang, Jihong Liu, Wen Song, Delin Ma
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-08-01
Series:	Frontiers in Pharmacology
Subjects:	botanical drugs natural products erectile dysfunction clinical study phosphodiesterase-5
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1232774/full

Similar Items

Endothelial Dysfunction, Erectile Dysfunction and Phosphodiesterase 5 Inhibitors. An Update of the Current Data and Future Perspectives
by: Angelis Konstantinopoulos, et al.
Published: (2007-01-01)

Obesity and Erectile Dysfunction: From Bench to Clinical Implication
by: Ki Hak Moon, et al.
Published: (2019-05-01)

An open-label, multicenter, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in Chinese men naïve to phosphodiesterase 5 inhibitor therapy
by: Wen-Jun Bai, et al.
Published: (2015-02-01)

Influence of regular use of vardenafil on endothelial and erectile functions in patients with arteriogenic erectile dysfunction
by: Safar Israilovich Gamidov, et al.
Published: (2009-10-01)

Erectile dysfunction in diabetes mellitus: A review
by: Deepak K Jumani, et al.
Published: (2020-01-01)

The pharmacological management of erectile dysfunction
by: Andre Marais
Published: (2015-07-01)

PHOSPHODIESTERASE-5 INHIBITORS USE IN PATIENTS WITH ERECTILE DYSFUNCTION AND CARDIOVASCULAR DISEASE IN CLINICAL PRACTICE
by: M. N. Mamedov, et al.
Published: (2016-01-01)

Pharmacotherapy of erectile dysfunction: Current standards
by: Kew-Kim Chew
Published: (2006-01-01)

Postprostatectomy Erectile Dysfunction: A Review
by: Paolo Capogrosso, et al.
Published: (2016-08-01)

Exercise training improves erectile dysfunction (ED) in patients with metabolic syndrome on phosphodiesterase-5 (PDE-5) inhibitors
by: Luigi Maresca, et al.
Published: (2013-12-01)

Molecular and Histologic Evidence of Novel Erectile Dysfunction Rat Model as an Aging Atherosclerosis Model: A Preliminary Study
by: Jae Heon Kim, et al.
Published: (2020-07-01)

Variations in Low Intensity Shockwave Treatment Protocols for Erectile Dysfunction: A Review of the Literature and Guide to Offering Treatment
by: Solomon Hayon, et al.
Published: (2024-04-01)

Erectile dysfunction in patients taking psychotropic drugs and treated with phosphodiesterase-5 inhibitors
by: Rossella Mazzilli, et al.
Published: (2018-03-01)

Pathophysiology of visual disorders induced by phosphodiesterase inhibitors in the treatment of erectile dysfunction
by: Moschos MM, et al.
Published: (2016-10-01)

Investigation of Cnidium monnieri compounds as phosphodiesterase-5 antagonists in erectile dysfunction via molecular docking and dynamic simulation
by: Damilola Alex Omoboyowa
Published: (2024-01-01)

Does the Daily Dose of Tadalafil for the Treatment of Erectile Dysfunction Increase Penile Sensation?
by: Selim Taş, et al.
Published: (2023-03-01)

Treatment of Erectile Dysfunction in Type 2 Diabetic Men
by: V.Ye. Luchytskyi
Published: (2015-11-01)

Pathological Significance of Macrophages in Erectile Dysfunction Including Peyronie’s Disease
by: Yasuyoshi Miyata, et al.
Published: (2021-11-01)

Peyronie′s disease and erectile dysfunction: Current understanding and future direction
by: Laurence A Levine
Published: (2006-01-01)

Recreational use of oral erectile dysfunction medications among male physicians - A cross-sectional study
by: Raed Almannie, et al.
Published: (2023-01-01)

Expectations do not Influence the Response to Phosphosdiesterase Type 5 Inhibitor Therapy for Erectile Dysfunction
by: Connie C. J. Louizos, et al.
Published: (2015-11-01)

Effects of different treatments on endothelial function in patients with erectile dysfunction and hypogonadism
by: E B Mazo, et al.
Published: (2008-12-01)

Audiovisual Sexual Stimulation and RigiScan Test for the Diagnosis of Erectile Dysfunction
by: Tao Wang, et al.
Published: (2018-01-01)

REVITALISE: A Large Observational Study Assessing the Safety and Effectiveness of Vardenafil in Men With Erectile Dysfunction and Metabolic Syndrome
by: Ridwan Shabsigh, MD, FACS, et al.
Published: (2016-09-01)

The erectile dysfunction
by: Johan Eduardo Ardila Jaimes
Published: (2002-12-01)

Gosha-Jinki-Gan Improved Erectile Dysfunction Caused by Anti-Cancer Agent Oxaliplatin by Decreasing Transcriptional Expression of Phosphodiesterase-5 in Rats
by: Tomoya Kataoka, PhD, et al.
Published: (2022-04-01)

Markers of erectile dysfunction
by: Kelvin P Davies, et al.
Published: (2008-01-01)

Inflammatory biomarkers may predict response to phosphodiesterase type 5 inhibitor treatment in patients with erectile dysfunction
by: Metin Kilic, et al.
Published: (2023-07-01)

Advances in Nanoparticle Delivery System for Erectile Dysfunction: An Updated Review
by: Nelisiwe Prenate Masuku, MSc, et al.
Published: (2021-10-01)

A meta-regression evaluating the effectiveness and prognostic factors of oral phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction
by: Jin-Qiu Yuan, et al.
Published: (2016-01-01)

Phosphodiesterase-5 inhibitors for erectile dysfunction in patients with diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials
by: Yatan Pal Singh Balhara, et al.
Published: (2015-01-01)

Erectile function in men with COVID-19 six months after recovery
by: E.V. Luchytskyi, et al.
Published: (2023-12-01)

Medical management of erectile dysfunction in aging males: is it too late to treat?
by: Kai Zhang, et al.
Published: (2014-02-01)

TREATMENT OF ERECTILE DYSFUNCTION IN PATIENTS WITH PROSTATE TUMOR AFTER RADICAL PROSTATECTOMY
by: A. V. Babintsev, et al.
Published: (2017-05-01)

Dietary Supplements for Erectile Dysfunction: Analysis of Marketed Products, Systematic Review, Meta-Analysis and Rational Use
by: Gabriel Cosmin Petre, et al.
Published: (2023-08-01)

Cardiovascular drugs and erectile dysfunction
by: Terzić Branka M., et al.
Published: (2014-01-01)

Incident gout and erectile dysfunction: is hyperuricaemia the elephant in the room?
by: Abhishek Abhishek, et al.
Published: (2017-08-01)

Erectile dysfunction and obesity
by: A S Ametov, et al.
Published: (2013-10-01)

Trazodone in Methandone Induced Erectile Dysfunction
by: Reza Faghih nasiri, et al.
Published: (2010-11-01)

Relationship between Response to PDE5 Inhibitors and Penile Duplex Doppler Ultrasound in Erectile Dysfunction
by: Ercan Ogreden, et al.
Published: (2018-03-01)